This announcement is great news for ACTC as it will likely prompt our government to take a closer look at this science to help stem the tide of ever escalating health care costs. Additionally, ACTC is the clear leader with the only human trials at the end of Phase I/II trials with any safety issues whatsoever. If the safety and results success continue, it is likely that the FDA will accelerate approvals to get the SMD/AMD unmet medical remedy to market sooner rather than later. All positive for ACTC and its shareholders. Big Pharma partners are fully aware and following our progress in the current clinical trials.
Facts, once again the facts are that ACTC is 5 cent stock, and it's CEO & Chairman is in hiding, so you can paint all the pretty pictures you want, but the facts are the facts, and you should know this more than anyone else, given your id.